Savant Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.92M | Buy |
23,242
+13,079
| +129% | +$1.64M | 0.02% | 453 |
|
|
2025
Q1 | $1.12M | Sell |
10,163
-6,380
| -39% | -$706K | 0.01% | 714 |
|
|
2024
Q4 | $2.26M | Buy |
+16,543
| New | +$2.26M | 0.02% | 409 |
|
|
2024
Q3 | – | Sell |
-7,163
| Closed | -$986K | – | 1436 |
|
|
2024
Q2 | $986K | Sell |
7,163
-8,430
| -54% | -$1.16M | 0.01% | 593 |
|
|
2024
Q1 | $2.15M | Buy |
+15,593
| New | +$2.15M | 0.02% | 335 |
|